lintuzumab
DESCRIPTION |
CATALOG # |
SIZE |
PRICE |
Anti-CD33 Therapeutic Antibody (ZAMYL/Smart) |
TAB-756 |
1mg |
Please Inquiry |
Product Detail
- Cat
- TAB-756
- Product Overview
- Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD33. Lintuzumab is a humanized monoclonal antibody used in the treatment of cancer.
- Target
- CD33
- Type
- IgG1 - kappa
- Immunogen
- The details of the immunogen for this antibody are not available.
- Species Reactivity
- Human
- Expression Host
- Sp2/0 mouse myeloma cells
- Applications
- Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
- CAS
- 166089-32-3
- Trade name
- zamyl/smart
- Predicted N terminal
- QVQLVQSG
- Molecular Weight
- 46.96 kDa
- Purity
- >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
- Size
- 1mg
- Storage
- Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Background
- Introduction
- Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer.
- Antigen Description
- CD33 or Siglec-3 is a transmembrane receptor expressed on cells of myeloid lineage.It is usually considered myeloid-specific, but it can also be found on some lymphoid cells.It binds sialic acids, therefore is a member of the SIGLEC family of lectins.
- Function
- receptor activity; sugar binding;
- Gene ID
- 945
- Synonyms
- CD33; CD33 molecule; CD33 antigen (gp67); myeloid cell surface antigen CD33; FLJ00391; p67; sialic acid binding Ig like lectin 3; SIGLEC 3; SIGLEC3; gp67; sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3; SIGLEC-3;
- Download Datasheet:
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Online Inquiry